Alex L Laursen Selected Research

Alex L Laursen Research Topics

8	Infections 01/2021 - 03/2003
5	Chronic Hepatitis C 01/2021 - 06/2011
2	Fibrosis (Cirrhosis) 06/2018 - 11/2017
2	Coinfection 11/2017 - 05/2006
2	HIV Infections (HIV Infection) 03/2013 - 05/2008
2	Disease Progression 12/2006 - 04/2004
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2006 - 04/2004
1	Vomiting 12/2017
1	Tachycardia (Tachyarrhythmias) 12/2017
1	Inflammation (Inflammations) 10/2011
1	Hepatitis B 05/2008

5	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
3	Ribavirin (Virazole)FDA LinkGeneric 12/2017 - 06/2011
3	InterferonsIBA 11/2017 - 06/2011
2	RNA (Ribonucleic Acid)IBA 01/2019 - 11/2017
2	grazoprevirIBA 12/2017 - 11/2017
2	uprifosbuvirIBA 12/2017 - 11/2017
2	ruzasvirIBA 12/2017 - 11/2017
1	Broadly Neutralizing AntibodiesIBA 01/2019
1	elbasvirIBA 11/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2014
1	telaprevirIBA 01/2014
1	E-SelectinIBA 10/2011
1	abacavir (Ziagen)FDA Link 10/2011
1	Biomarkers (Surrogate Marker)IBA 10/2011
1	Tenofovir (Viread)FDA Link 10/2011
1	entecavir FDA Link 05/2008
1	Cysteine (L-Cysteine)FDA Link 12/2006
1	Proteins (Proteins, Gene)FDA Link 04/2004
1	Immunoglobulin A (IgA)IBA 03/2003
1	Immunoglobulin G (IgG)IBA 03/2003
1	Complement System Proteins (Complement)IBA 03/2003

3	Therapeutics 12/2017 - 05/2008
1	Retreatment 01/2021
1	Art Therapy 03/2013
1	Highly Active Antiretroviral Therapy (HAART) 05/2006